These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25066738)

  • 1. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats.
    Park ME; Lee SY; Kim RH; Ko MK; Lee KN; Kim SM; Kim BK; Lee JS; Kim B; Park JH
    Vaccine; 2014 Sep; 32(40):5221-7. PubMed ID: 25066738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
    Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compared to Aluminum Hydroxide Adjuvant, Montanide ISA 206 VG Induces a Higher and More Durable Neutralizing Antibody Response against FMDV in Goats.
    Taghizadeh M; Azimi SM; Dabaghian M
    Arch Razi Inst; 2023 Dec; 78(6):1843-1851. PubMed ID: 38828163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
    Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
    Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
    Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
    Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses of goats against foot-and-mouth disease quadrivalent vaccine: comparison of double oil emulsion and aluminium hydroxide gel vaccines in eliciting immunity.
    Patil PK; Bayry J; Ramakrishna C; Hugar B; Misra LD; Natarajan C
    Vaccine; 2002 Jun; 20(21-22):2781-9. PubMed ID: 12034105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
    Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
    J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A
    Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies.
    Patil PK; Sajjanar CM; Natarajan C; Bayry J
    Vet Microbiol; 2014 Mar; 169(3-4):233-5. PubMed ID: 24508311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes.
    Cloete M; Dungu B; Van Staden LI; Ismail-Cassim N; Vosloo W
    Onderstepoort J Vet Res; 2008 Mar; 75(1):17-31. PubMed ID: 18575060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.
    Patil PK; Bayry J; Ramakrishna C; Hugar B; Misra LD; Prabhudas K; Natarajan C
    J Clin Microbiol; 2002 Nov; 40(11):4367-71. PubMed ID: 12409434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs.
    Wu P; Zhang Y; Yin X; He Y; Zhang Q; Chen C
    BMC Vet Res; 2020 Dec; 16(1):474. PubMed ID: 33276787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs.
    Hwang JH; Lee KN; Kim SM; Lee G; Moon Y; Kim B; Lee JS; Park JH
    J Vet Sci; 2019 May; 20(3):e29. PubMed ID: 31161747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant.
    Quattrocchi V; Pappalardo JS; Langellotti C; Smitsaart E; Fondevila N; Zamorano P
    Vaccine; 2014 Apr; 32(19):2167-72. PubMed ID: 24631088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mincle and STING-Stimulating Adjuvants Elicit Robust Cellular Immunity and Drive Long-Lasting Memory Responses in a Foot-and-Mouth Disease Vaccine.
    Lee MJ; Jo H; Shin SH; Kim SM; Kim B; Shim HS; Park JH
    Front Immunol; 2019; 10():2509. PubMed ID: 31736952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.